F
Friedrich K. Port
Researcher at University of Michigan
Publications - 409
Citations - 54004
Friedrich K. Port is an academic researcher from University of Michigan. The author has contributed to research in topics: Dialysis & Hemodialysis. The author has an hindex of 107, co-authored 403 publications receiving 50165 citations. Previous affiliations of Friedrich K. Port include Amgen & Michigan State University.
Papers
More filters
Journal ArticleDOI
The US Renal Data System at 30 Years: A Historical Perspective.
Friedrich K. Port,Philip J. Held +1 more
Journal ArticleDOI
Response to ‘Mortality risk for patients receiving hemodiafiltration versus hemodialysis’
Bernard Canaud,J. L. Bragg-Gresham,Mark R. Marshall,S. Desmeules,Brenda W. Gillespie,Tom Depner,Preston S. Klassen,Friedrich K. Port +7 more
TL;DR: Findings showing that high-efficiency convective therapies, such as online HDF, may offer an interesting alternative to improve dialysis patient outcomes are supported.
Evaluation of acetate tolerance during highly efficient hemodialysis.
Friedrich K. Port,R E Easterling +1 more
TL;DR: Acetate clearance was found to approximate bicarbonate clearance and to be 10% lower than urea clearance under single pass in vitro conditions and Correction of pre-dialysis acidosis may be impaired by acetate accumulation.
Journal ArticleDOI
Estimating the Fraction of First-Year Hemodialysis Deaths Attributable to Potentially Modifiable Risk Factors: Results from the DOPPS
Angelo Karaboyas,Hal Morgenstern,Yun Li,Brian Bieber,Raymond M. Hakim,Takeshi Hasegawa,Michel Jadoul,Elke Schaeffner,Raymond Vanholder,Ronald L. Pisoni,Friedrich K. Port,Bruce M. Robinson +11 more
TL;DR: A substantial proportion of first-year HD deaths could be prevented by successfully modifying a few risk factors, and highest priorities should be decreasing catheter use and limiting malnutrition/inflammation whenever possible.
Journal ArticleDOI
Effect of acetate administration on blood lipids.
TL;DR: In this short-term study, acetate does not appear to be a major contributing factor for the hyperlipidemia of dialysis patients.